一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Vecuronium bromide

Vecuronium bromide ??? ???
?? ??:
50700-72-6
???:
Vecuronium bromide
???(??):
vecuronium;norcuron;Vecuronim Bromide;VBMC;nc-45;orgnc45;Musculax;Muscurate;mide,diacetate;VECRONIUM BROMIDE
CBNumber:
CB3382859
???:
C34H57BrN2O4
??? ??:
637.73138
MOL ??:
50700-72-6.mol
MSDS ??:
SDS

Vecuronium bromide ??

???
227-229°C
??
+30.5~+35.0゜(D/20℃)(c=0.5,dil.HCl)
?? ??
Inert atmosphere,Store in freezer, under -20°C
???
?? ?? ???? ?????? ?? ???? ?????? ? ?? ???? ?? ?????.
??? ??
Solid
??
???
???? ??
synthetic
Merck
14,9941
BRN
4837308
???
???
InChIKey
VEPSYABRBFXYIB-PWXDFCLTSA-M
SMILES
[Br-].CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1N6CCCCC6
CAS ??????
50700-72-6(CAS DataBase Reference)
??
  • ?? ? ?? ??
  • ?? ? ???? ?? (GHS)
??? ?? Xi,Xn
?? ???? ?? 36/37/38-22
????? 26-37/39
WGK ?? 3
RTECS ?? TN4875000
HS ?? 2933399090
???? ??? 11 - Combustible Solids
Hazard Classifications Acute Tox. 4 Oral
?? LD50 in mice: 0.061 mg/kg i.v. (Buckett)
????(GHS): Exclamation Mark (GHS07)
?? ?: Warning
??·?? ??:
?? ??·?? ?? ?? ?? ?? ?? ? ?? ?? P- ??
H302 ??? ??? ?? ?? ?? - ?? ?? 4 ?? P264, P270, P301+P312, P330, P501
??????:
NFPA 704
0
2 0

Vecuronium bromide MSDS


(+)-1-(3,17-Diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium bromide

Vecuronium bromide C??? ??, ??, ??

??

Vecuronium, 1-[(2β,3α,5α,16β,17β,)-3,17-bis(acetyloxy)-2-(1-piperidinyl) androstan-16-yl]-1-methylpiperidinium bromide (15.1.9), differs from panuronium only in the extent of alkylation. Only the piperidine substituent on C16 of the steroid skeleton is transformed into a quaternary salt.

??? ??

White Solid

??

An aminosteroid, competitive neuromuscular blocker agent.

??

ChEBI: The organic bromide salt of a 5alpha-androstane compound having 3alpha-acetoxy-, 17beta-acetoxy-, 2beta-piperidinino- and 16beta-N-methylpiperidinium su stituents.

Biological Functions

Vecuronium bromide (Norcuron) is chemically identical to pancuronium except for a tertiary amine in place of a quaternary nitrogen. However, some of the drug will exist as the bisquaternary compound, depending on body pH. Vecuronium has a moderate onset of action (2.4 minutes) and a duration of effect of about 50 minutes. Like pancuronium, it does not block ganglia or vagal neuroeffector junctions, does not release histamine, and is eliminated by urinary excretion.

?? ??

Vecuronium bromide, 1-(3 ,17 -dihydroxy-2 -piperidino-5 -androstan-16 -yl)-1-methylpiperidinium bromide diacetate (Norcuron), is themonoquaternary analog of pancuronium bromide. It belongsto the class of nondepolarizing neuromuscular blockingagents and produces effects similar to those of drugs in thisclass. It is unstable in the presence of acids and undergoesgradual hydrolysis of its ester functions in aqueous solution.Aqueous solutions have a pH of about 4.0.

Mechanism of action

Vecuronium bromide is a bisquaternary nitrogen compound that acts by competitively binding to nicotinic cholinergic receptors. The binding of vecuronium decreases the opportunity for acetylcholine to bind to the nicotinic receptor at the postjunctional membrane of the myoneural junction. As a result, depolarization is prevented, calcium ions are not released and muscle contraction does not occur.

Pharmacology

Vecuronium bromide is steroidal agent that was developed in an attempt to reduce the cardiovascular effects of pancuronium. I t is similar in structure to the older drug, differing only in the loss of a methyl group from one quaternary ammonium radical. Thus it is a monoquaternary amine. An intubating dose of 0.1mgkg-1 produces profound neuromuscular block within 3min. This dose produces clinical block for about 30min. Vecuronium rarely produces histamine release, nor does it have any direct cardiovascular effects, although it allows the cardiac effects of other anaesthetic agents, such as bradycardia produced by the opioids, to go unchallenged. Vecuronium is excreted through the kidneys (30%), although to a lesser extent than pancuronium, and undergoes hepatic deacetylation; the deacetylated metabolites have neuromuscular blocking properties. Repeated doses should be used with care in patients with renal or hepatic disease because they accumulate.

Clinical Use

Vecuronium Bromide is usedmainly to produce skeletal muscle relaxation during surgeryand to assist in controlled respiration after general anesthesiahas been induced.

Vecuronium bromide ?? ?? ? ???

???

?? ??


Vecuronium bromide ?? ??

???( 498)?? ??
??? ?? ??? ?? ?? ? ??
Beijing Mesochem Technology Co.,Ltd
+8613651027935
rachel@mesochem.com China 191 58
Hebei Chuanghai Biotechnology Co., Ltd
+8615350571055
Sibel@chuanghaibio.com China 8738 58
Hebei Chuanghai Biotechnology Co,.LTD
+86-86-13131129325 +8613131129325
sales1@chuanghaibio.com China 5228 58
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
+86-18600796368
sales@sjar-tech.com China 529 58
Beijing Cooperate Pharmaceutical Co.,Ltd
010-60279497
sales01@cooperate-pharm.com CHINA 1803 55
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21586 55
career henan chemical co
+86-0371-86658258 +8613203830695
sales@coreychem.com China 29815 58
Xiamen AmoyChem Co., Ltd
+86-86-5926051114 +8615060885618
sales@amoychem.com China 6366 58
Shandong chuangyingchemical Co., Ltd.
18853181302
sale@chuangyingchem.com CHINA 5906 58
Beijing Yibai Biotechnology Co., Ltd
0086-182-6772-3597
sales04@yibaibiotech.com CHINA 419 58

Vecuronium bromide ?? ??:

Copyright 2019 ? ChemicalBook. All rights reserved
厦门市| 丰宁| 明水县| 厦门市| 泸溪县| 准格尔旗| 织金县| 吴江市| 陆河县| 闽清县| 中江县| 汝南县| 乌拉特前旗| 石家庄市| 翁源县| 建德市| 响水县| 庆云县| 宿迁市| 筠连县| 卓尼县| 青海省| 堆龙德庆县| 界首市| 金川县| 福泉市| 堆龙德庆县| 石渠县| 岳西县| 句容市| 黔南| 娄烦县| 三穗县| 盐源县| 南投县| 苏尼特左旗| 雷山县| 图木舒克市| 清流县| 香港| 本溪市|